{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:08:01Z","timestamp":1767856081811,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n","award":["HUFA Award 2018"],"award-info":[{"award-number":["HUFA Award 2018"]}]},{"name":"Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n","award":["HUFA Award 2018"],"award-info":[{"award-number":["HUFA Award 2018"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n \u2013 Agencia Estatal de Investigaci\u00f3n and Fondo Europeo de Desarrollo Regional","award":["PID2022-138461OB-I00"],"award-info":[{"award-number":["PID2022-138461OB-I00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70172-5","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:31:05Z","timestamp":1724434265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circulating endocannabinoid levels in SARS-CoV-2 infection and their potential role in the inflammatory response"],"prefix":"10.1038","volume":"14","author":[{"given":"Maria","family":"Velasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Posada-Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"P\u00e9rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frida","family":"Loria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Amores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Miguel","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Jaime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ruth","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"1","key":"70172_CR1","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1038\/s41598-021-91859-z","volume":"11","author":"LG G\u00f3mez-Escobar","year":"2021","unstructured":"G\u00f3mez-Escobar, L. G. et al. Cytokine signatures of end organ injury in COVID-19. Sci. Rep. 11(1), 12606. https:\/\/doi.org\/10.1038\/s41598-021-91859-z (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"70172_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/medicina58020144","volume":"58","author":"C Zanza","year":"2022","unstructured":"Zanza, C. et al. Cytokine storm in COVID-19: Immunopathogenesis and therapy. Medicina 58(2), 144. https:\/\/doi.org\/10.3390\/medicina58020144 (2022).","journal-title":"Medicina"},{"issue":"10","key":"70172_CR3","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26(10), 1636\u20131643. https:\/\/doi.org\/10.1038\/s41591-020-1051-9 (2020).","journal-title":"Nat. Med."},{"key":"70172_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","volume":"95","author":"Z Zhu","year":"2020","unstructured":"Zhu, Z. et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int. J. Infect. Dis. 95, 332\u2013339. https:\/\/doi.org\/10.1016\/j.ijid.2020.04.041 (2020).","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"70172_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","volume":"9","author":"H Han","year":"2020","unstructured":"Han, H. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 9(1), 1123\u20131130. https:\/\/doi.org\/10.1080\/22221751.2020.1770129 (2020).","journal-title":"Emerg. Microbes Infect."},{"issue":"5","key":"70172_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers, M. M. & Haagmans, B. L. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 20(5), 270\u2013284. https:\/\/doi.org\/10.1038\/s41579-022-00713-0 (2022).","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"70172_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ddr.21752","volume":"82","author":"MF Meeran","year":"2021","unstructured":"Meeran, M. F., Sharma, C., Goyal, S. N., Kumar, S. & Ojha, S. CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections. Drug Dev. Res. 82(1), 7\u201311. https:\/\/doi.org\/10.1002\/ddr.21752 (2021).","journal-title":"Drug Dev. Res."},{"issue":"2","key":"70172_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(00)00307-6","volume":"109","author":"P Sacerdote","year":"2000","unstructured":"Sacerdote, P., Massi, P., Panerai, A. E. & Parolaro, D. In Vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: Involvement of both CB1 and CB2 receptors. J. Neuroimmunol. 109(2), 155\u2013163. https:\/\/doi.org\/10.1016\/S0165-5728(00)00307-6 (2000).","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"70172_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","volume":"97","author":"C Turcotte","year":"2015","unstructured":"Turcotte, C., Chouinard, F., Lefebvre, J. S. & Flamand, N. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. J. Leukoc. Biol. 97(6), 1049\u20131070. https:\/\/doi.org\/10.1189\/jlb.3RU0115-021R (2015).","journal-title":"J. Leukoc. Biol."},{"key":"70172_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","volume":"49","author":"M Mecha","year":"2015","unstructured":"Mecha, M. et al. Endocannabinoids drive the acquisition of an alternative phenotype in Microglia. Brain Behav. Immun. 49, 233\u2013245. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.002 (2015).","journal-title":"Brain Behav. Immun."},{"issue":"2\u20133","key":"70172_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0014-2999(03)02074-0","volume":"474","author":"A Franklin","year":"2003","unstructured":"Franklin, A. & Stella, N. Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur. J. Pharmacol. 474(2\u20133), 195\u2013198. https:\/\/doi.org\/10.1016\/S0014-2999(03)02074-0 (2003).","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"70172_CR12","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.3390\/ijms21113809","volume":"21","author":"F Rossi","year":"2020","unstructured":"Rossi, F., Tortora, C., Argenziano, M., Di Paola, A. & Punzo, F. Cannabinoid receptor Type 2: A possible target in SARS-CoV-2 (CoV-19) infection?. IJMS 21(11), 3809. https:\/\/doi.org\/10.3390\/ijms21113809 (2020).","journal-title":"IJMS"},{"issue":"21","key":"70172_CR13","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1111\/bph.15157","volume":"177","author":"G Esposito","year":"2020","unstructured":"Esposito, G. et al. The potential of cannabidiol in the COVID-19 pandemic. Br. J. Pharmacol. 177(21), 4967\u20134970. https:\/\/doi.org\/10.1111\/bph.15157 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"70172_CR14","doi-asserted-by":"publisher","first-page":"631233","DOI":"10.3389\/fimmu.2021.631233","volume":"12","author":"N Paland","year":"2021","unstructured":"Paland, N. et al. The immunopathology of COVID-19 and the cannabis paradigm. Front. Immunol. 12, 631233. https:\/\/doi.org\/10.3389\/fimmu.2021.631233 (2021).","journal-title":"Front. Immunol."},{"issue":"11","key":"70172_CR15","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00705-021-05223-7","volume":"166","author":"M Rastegar","year":"2021","unstructured":"Rastegar, M. et al. Functional Variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: A human study and molecular docking. Arch. Virol. 166(11), 3117\u20133126. https:\/\/doi.org\/10.1007\/s00705-021-05223-7 (2021).","journal-title":"Arch. Virol."},{"issue":"3","key":"70172_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","volume":"19","author":"S Zou","year":"2018","unstructured":"Zou, S. & Kumar, U. Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. IJMS 19(3), 833. https:\/\/doi.org\/10.3390\/ijms19030833 (2018).","journal-title":"IJMS"},{"issue":"4","key":"70172_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee, R. G. et al. International union of basic and clinical pharmacology. LXXIX cannabinoid receptors and their ligands: Beyond CB1 and CB2. Pharmacol. Rev. 62(4), 588\u2013631. https:\/\/doi.org\/10.1124\/pr.110.003004 (2010).","journal-title":"Pharmacol. Rev."},{"issue":"43","key":"70172_CR18","doi-asserted-by":"publisher","first-page":"33744","DOI":"10.1074\/jbc.M007088200","volume":"275","author":"KR Kozak","year":"2000","unstructured":"Kozak, K. R., Rowlinson, S. W. & Marnett, L. J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem. 275(43), 33744\u201333749. https:\/\/doi.org\/10.1074\/jbc.M007088200 (2000).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"70172_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard, C. J. Circulating endocannabinoids: From whence do they come and where are they going?. Neuropsychopharmacol. 43(1), 155\u2013172. https:\/\/doi.org\/10.1038\/npp.2017.130 (2018).","journal-title":"Neuropsychopharmacol."},{"issue":"2","key":"70172_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/v15020573","volume":"15","author":"JCS De Carvalho","year":"2023","unstructured":"De Carvalho, J. C. S. et al. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses 15(2), 573. https:\/\/doi.org\/10.3390\/v15020573 (2023).","journal-title":"Viruses"},{"issue":"12","key":"70172_CR21","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.3390\/ijms16047057","volume":"16","author":"E Patsenker","year":"2015","unstructured":"Patsenker, E. et al. Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation. IJMS 16(12), 7057\u20137076. https:\/\/doi.org\/10.3390\/ijms16047057 (2015).","journal-title":"IJMS"},{"issue":"1","key":"70172_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1742-2094-8-102","volume":"8","author":"L Mestre","year":"2011","unstructured":"Mestre, L. et al. Anandamide inhibits theiler\u2019s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors. J. Neuroinflamm. 8(1), 102. https:\/\/doi.org\/10.1186\/1742-2094-8-102 (2011).","journal-title":"J. Neuroinflamm."},{"key":"70172_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mcn.2014.01.001","volume":"59","author":"G Krishnan","year":"2014","unstructured":"Krishnan, G. & Chatterjee, N. Endocannabinoids affect innate immunity of muller glia during HIV-1 tat cytotoxicity. Mol. Cell. Neurosci. 59, 10\u201323. https:\/\/doi.org\/10.1016\/j.mcn.2014.01.001 (2014).","journal-title":"Mol. Cell. Neurosci."},{"issue":"4","key":"70172_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/03602532.2021.1895204","volume":"53","author":"O Lucaciu","year":"2021","unstructured":"Lucaciu, O. et al. In quest of a new therapeutic approach in COVID-19: The endocannabinoid system. Drug Metab. Rev. 53(4), 478\u2013490. https:\/\/doi.org\/10.1080\/03602532.2021.1895204 (2021).","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"70172_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/biom13010033","volume":"13","author":"A Schiano Moriello","year":"2023","unstructured":"Schiano Moriello, A. et al. First evidence of the protective effects of 2-pentadecyl-2-oxazoline (PEA-OXA) in In vitro models of acute lung injury. Biomolecules 13(1), 33. https:\/\/doi.org\/10.3390\/biom13010033 (2023).","journal-title":"Biomolecules"},{"issue":"6","key":"70172_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bpsc.2020.07.016","volume":"6","author":"H-C Lu","year":"2021","unstructured":"Lu, H.-C. & Mackie, K. Review of the endocannabinoid system. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 6(6), 607\u2013615. https:\/\/doi.org\/10.1016\/j.bpsc.2020.07.016 (2021).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"1","key":"70172_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.24292","volume":"88","author":"A Tahamtan","year":"2016","unstructured":"Tahamtan, A., Tavakoli-Yaraki, M., Rygiel, T. P., Mokhtari-Azad, T. & Salimi, V. Effects of cannabinoids and their receptors on viral infections. J. Med. Virol. 88(1), 1\u201312. https:\/\/doi.org\/10.1002\/jmv.24292 (2016).","journal-title":"J. Med. Virol."},{"issue":"2","key":"70172_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cgh.2013.05.008","volume":"12","author":"N Coppola","year":"2014","unstructured":"Coppola, N. et al. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C. Clin. Gastroenterol. Hepatol. 12(2), 334\u2013340. https:\/\/doi.org\/10.1016\/j.cgh.2013.05.008 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"70172_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/21505594.2017.1389369","volume":"9","author":"A Tahamtan","year":"2018","unstructured":"Tahamtan, A. et al. Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice. Virulence 9(1), 217\u2013230. https:\/\/doi.org\/10.1080\/21505594.2017.1389369 (2018).","journal-title":"Virulence"},{"key":"70172_CR30","doi-asserted-by":"publisher","unstructured":"Rastgar, M., Samadizadeh, S., Yasaghi, M., Moradi, A., Tabarraei, A., Salimi, V., Tahamtan, A. Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with COVID-19 Severity: From Human Study to Molecular Docking; preprint, In review (2021). https:\/\/doi.org\/10.21203\/rs.3.rs-144850\/v1.","DOI":"10.21203\/rs.3.rs-144850\/v1"},{"key":"70172_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mam.2018.10.001","volume":"64","author":"BA Watkins","year":"2018","unstructured":"Watkins, B. A. Endocannabinoids, exercise, pain, and a path to health with aging. Mol. Aspects Med. 64, 68\u201378. https:\/\/doi.org\/10.1016\/j.mam.2018.10.001 (2018).","journal-title":"Mol. Aspects Med."},{"issue":"7","key":"70172_CR32","doi-asserted-by":"publisher","first-page":"e0132042","DOI":"10.1371\/journal.pone.0132042","volume":"10","author":"S Gouveia-Figueira","year":"2015","unstructured":"Gouveia-Figueira, S., Sp\u00e4th, J., Zivkovic, A. M. & Nording, M. L. Profiling the oxylipin and endocannabinoid metabolome by UPLC-ESI-MS\/MS in human plasma to monitor postprandial inflammation. PLoS ONE 10(7), e0132042. https:\/\/doi.org\/10.1371\/journal.pone.0132042 (2015).","journal-title":"PLoS ONE"},{"issue":"2","key":"70172_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3233\/JAD-142349","volume":"46","author":"C Altamura","year":"2015","unstructured":"Altamura, C. et al. Elevation of plasma 2-arachidonoylglycerol levels in alzheimer\u2019s disease patients as a potential protective mechanism against neurodegenerative decline. JAD 46(2), 497\u2013506. https:\/\/doi.org\/10.3233\/JAD-142349 (2015).","journal-title":"JAD"},{"key":"70172_CR34","doi-asserted-by":"publisher","first-page":"104801","DOI":"10.1016\/j.psyneuen.2020.104801","volume":"120","author":"EJ Harfmann","year":"2020","unstructured":"Harfmann, E. J. et al. Circulating endocannabinoid concentrations in grieving adults. Psychoneuroendocrinology 120, 104801. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104801 (2020).","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"70172_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/mus.27096","volume":"63","author":"GT Carter","year":"2021","unstructured":"Carter, G. T. et al. Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. Muscle and Nerve 63(1), 120\u2013126. https:\/\/doi.org\/10.1002\/mus.27096 (2021).","journal-title":"Muscle and Nerve"},{"key":"70172_CR36","doi-asserted-by":"publisher","first-page":"1004002","DOI":"10.3389\/fnagi.2022.1004002","volume":"14","author":"N Forte","year":"2022","unstructured":"Forte, N. et al. Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in alzheimer\u2019s disease. Front. Aging Neurosci. 14, 1004002. https:\/\/doi.org\/10.3389\/fnagi.2022.1004002 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"70172_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clnesp.2023.02.020","volume":"55","author":"K Ota","year":"2023","unstructured":"Ota, K. et al. The association of circulating endocannabinoids with cancer cachexia: A cross-sectional study. Clin. Nutr. ESPEN 55, 20\u201329. https:\/\/doi.org\/10.1016\/j.clnesp.2023.02.020 (2023).","journal-title":"Clin. Nutr. ESPEN"},{"issue":"3","key":"70172_CR38","doi-asserted-by":"publisher","first-page":"e1010042","DOI":"10.1371\/journal.pgen.1010042","volume":"18","author":"AB Palmos","year":"2022","unstructured":"Palmos, A. B. et al. Proteome-wide mendelian randomization identifies causal links between blood proteins and severe COVID-19. PLoS Genet 18(3), e1010042. https:\/\/doi.org\/10.1371\/journal.pgen.1010042 (2022).","journal-title":"PLoS Genet"},{"issue":"1","key":"70172_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-pharmtox-030220-112741","volume":"61","author":"N Van Egmond","year":"2021","unstructured":"Van Egmond, N., Straub, V. M. & Van Der Stelt, M. Targeting endocannabinoid signaling: FAAH and MAG lipase inhibitors. Annu. Rev. Pharmacol. Toxicol. 61(1), 441\u2013463. https:\/\/doi.org\/10.1146\/annurev-pharmtox-030220-112741 (2021).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"70172_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.bjp.0707424","volume":"152","author":"I Matias","year":"2007","unstructured":"Matias, I. et al. Role and regulation of acylethanolamides in energy balance: Focus on adipocytes and \u03b2-cells. Br. J. Pharmacol. 152(5), 676\u2013690. https:\/\/doi.org\/10.1038\/sj.bjp.0707424 (2007).","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"70172_CR41","doi-asserted-by":"publisher","first-page":"18392","DOI":"10.1002\/jcp.28474","volume":"234","author":"E Yao","year":"2019","unstructured":"Yao, E. et al. Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1\/AMPK activation. J. Cell. Physiol. 234(10), 18392\u201318407. https:\/\/doi.org\/10.1002\/jcp.28474 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"70172_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/nu15010224","volume":"15","author":"C Santa-Mar\u00eda","year":"2023","unstructured":"Santa-Mar\u00eda, C. et al. Update on anti-inflammatory molecular mechanisms induced by oleic acid. Nutrients 15(1), 224. https:\/\/doi.org\/10.3390\/nu15010224 (2023).","journal-title":"Nutrients"},{"issue":"6","key":"70172_CR43","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s12276-021-00622-x","volume":"53","author":"E-K Kwon","year":"2021","unstructured":"Kwon, E.-K. et al. Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma. Exp. Mol. Med. 53(6), 1036\u20131045. https:\/\/doi.org\/10.1038\/s12276-021-00622-x (2021).","journal-title":"Exp. Mol. Med."},{"key":"70172_CR44","doi-asserted-by":"publisher","first-page":"126945","DOI":"10.1016\/j.jtemb.2022.126945","volume":"71","author":"N Akbari","year":"2022","unstructured":"Akbari, N. et al. Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial. J. Trace Elem. Med. Biol. 71, 126945. https:\/\/doi.org\/10.1016\/j.jtemb.2022.126945 (2022).","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"1","key":"70172_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-020-2096-3","volume":"22","author":"HT Philpott","year":"2020","unstructured":"Philpott, H. T. & McDougall, J. J. Combatting joint pain and inflammation by dual inhibition of monoacylglycerol lipase and cyclooxygenase-2 in a rat model of osteoarthritis. Arthritis Res. Ther. 22(1), 9. https:\/\/doi.org\/10.1186\/s13075-020-2096-3 (2020).","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"70172_CR46","doi-asserted-by":"publisher","first-page":"e862","DOI":"10.1038\/cddis.2013.387","volume":"4","author":"S Valdeolivas","year":"2013","unstructured":"Valdeolivas, S. et al. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: A potential role of cyclooxygenase-2-dependent metabolism of 2-AG. Cell Death Dis 4(10), e862\u2013e862. https:\/\/doi.org\/10.1038\/cddis.2013.387 (2013).","journal-title":"Cell Death Dis"},{"issue":"9","key":"70172_CR47","doi-asserted-by":"publisher","first-page":"e107407","DOI":"10.1371\/journal.pone.0107407","volume":"9","author":"B \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir, B. et al. Endocannabinoids and inflammatory response in periodontal ligament cells. PLoS ONE 9(9), e107407. https:\/\/doi.org\/10.1371\/journal.pone.0107407 (2014).","journal-title":"PLoS ONE"},{"key":"70172_CR48","doi-asserted-by":"publisher","unstructured":"Rocha Santos Passos, F., Heimfarth, L., Souza Monteiro, B., Bani Corr\u00eaa, C., Rodrigues De Moura, T., Antunes De Souza Ara\u00fajo, A., Ricardo Martins-Filho, P., Quintans-J\u00fanior, L. J., De Souza Siqueira Quintans, J. Oxidative Stress and Inflammatory Markers in Patients with COVID-19: Potential Role of RAGE, HMGB1, GFAP and COX-2 in Disease Severity. Int. Immunopharmacol. 2022, 104, 108502. https:\/\/doi.org\/10.1016\/j.intimp.2021.108502.","DOI":"10.1016\/j.intimp.2021.108502"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70172-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:34:42Z","timestamp":1724434482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70172-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70172"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70172-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19558"}}